BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33634606)

  • 21. Seven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; Kanter KR; McBride LR; Kaiser GC; Barner HB; Miller LW; Naunheim KS; Fiore AC; Willman V
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.
    Asaumi Y; Yasuda S; Morii I; Kakuchi H; Otsuka Y; Kawamura A; Sasako Y; Nakatani T; Nonogi H; Miyazaki S
    Eur Heart J; 2005 Oct; 26(20):2185-92. PubMed ID: 16014643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulatory support with paracorporeal pneumatic ventricular assist device (VAD) in infants and children.
    Ishino K; Loebe M; Uhlemann F; Weng Y; Hennig E; Hetzer R
    Eur J Cardiothorac Surg; 1997 May; 11(5):965-72. PubMed ID: 9196316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
    Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
    J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoadsorption in cardiac shock with bi ventricular failure and giant-cell myocarditis: A case report.
    Dogan G; Hanke J; Puntigam J; Haverich A; Schmitto JD
    Int J Artif Organs; 2018 Aug; 41(8):474-479. PubMed ID: 29843541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TandemHeart pVAD in the treatment of acute fulminant myocarditis.
    Khalife WI; Kar B
    Tex Heart Inst J; 2007; 34(2):209-13. PubMed ID: 17622371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with temporary right ventricular mechanical circulatory support.
    Bhama JK; Bansal U; Winger DG; Teuteberg JJ; Bermudez C; Kormos RL; Bansal A
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1885-1891. PubMed ID: 29861112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
    Wilde J; Klingel K; Kandolf R; Schuler G; Sandri M
    Dtsch Med Wochenschr; 2013 Mar; 138(12):576-80. PubMed ID: 23483417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful explantation of a left ventricular assist device following acute fulminant myocarditis.
    El-Hamamsy I; White M; Pellerin M; Demers P; Bouchard D; Leung TK; Perrault LP; Carrier M
    Can J Cardiol; 2006 May; 22(6):507-8. PubMed ID: 16685316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When the heart gets the flu: Fulminant influenza B myocarditis: A case-series report and review of the literature.
    Hékimian G; Jovanovic T; Bréchot N; Lebreton G; Leprince P; Trouillet JL; Schmidt M; Nieszkowska A; Besset S; Chastre J; Combes A; Luyt CE
    J Crit Care; 2018 Oct; 47():61-64. PubMed ID: 29929152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of survival and ability to wean from short-term mechanical circulatory support device following acute myocardial infarction complicated by cardiogenic shock.
    Garan AR; Eckhardt C; Takeda K; Topkara VK; Clerkin K; Fried J; Masoumi A; Demmer RT; Trinh P; Yuzefpolskaya M; Naka Y; Burkhoff D; Kirtane A; Colombo PC; Takayama H
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):755-765. PubMed ID: 29094607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous extracorporeal membrane oxygenation for cardiogenic shock due to acute fulminant myocarditis.
    Fayssoil A; Nardi O; Orlikowski D; Combes A; Chastre J; Annane D
    Ann Thorac Surg; 2010 Feb; 89(2):614-6. PubMed ID: 20103358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pediatric mechanical circulatory assistance. Biventricular assistance for fulminant myocarditis in a 5 year old child].
    Grinda JM; Guibourt P; Bricourt MO; Pelissier J; Salvi S; Fabiani JN; Deloche A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):921-4. PubMed ID: 15521487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery.
    Stein-Merlob AF; Hsu JJ; Colton B; Berg CJ; Ferreira A; Price MM; Wainberg Z; Baas AS; Deng MC; Parikh RV; Yang EH
    ESC Heart Fail; 2021 Oct; 8(5):4301-4306. PubMed ID: 34390221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse.
    Kawahito K; Murata S; Yasu T; Adachi H; Ino T; Saito M; Misawa Y; Fuse K; Shimada K
    Am J Cardiol; 1998 Oct; 82(7):910-1. PubMed ID: 9781978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.
    Andrade JG; Al-Saloos H; Jeewa A; Sandor GG; Cheung A
    J Heart Lung Transplant; 2010 Jan; 29(1):96-7. PubMed ID: 19782584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical variability within the INTERMACS 1 profile: implications for treatment options.
    Dutt DP; Pinney SP
    Curr Opin Cardiol; 2014 May; 29(3):244-9. PubMed ID: 24694386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant Cell, Giant Problems: A Case of Giant Cell Myocarditis Complicated by Cardiogenic Shock and Refractory Ventricular Tachycardia Managed With a Mechanical Circulatory Support Device.
    Goulbourne CA; Sharma N; Cecchini MJ; Bloom M; Singh A; Skopicki H; Pyo R
    Cardiovasc Revasc Med; 2021 Jul; 28S():180-185. PubMed ID: 33574004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Children may survive severe myocarditis with prolonged use of biventricular assist devices.
    Stiller B; Dähnert I; Weng YG; Hennig E; Hetzer R; Lange PE
    Heart; 1999 Aug; 82(2):237-40. PubMed ID: 10409544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.